Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis
Chronic lung allograft dysfunction (CLAD) and interstitial lung disease associated with collagen tissue diseases (CTD-ILD) are two end-stage lung disorders in which different chronic triggers induce activation of myo-/fibroblasts (LFs). Everolimus, an mTOR inhibitor, can be adopted as a potential st...
Main Authors: | Laura Pandolfi, Alessandro Marengo, Kamila Bohne Japiassu, Vanessa Frangipane, Nicolas Tsapis, Valeria Bincoletto, Veronica Codullo, Sara Bozzini, Monica Morosini, Sara Lettieri, Valentina Vertui, Davide Piloni, Silvia Arpicco, Elias Fattal, Federica Meloni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/14/7743 |
Similar Items
-
Hyaluronic Acid-Decorated Chitosan Nanoparticles for CD44-Targeted Delivery of Everolimus
by: Enrica Chiesa, et al.
Published: (2018-08-01) -
Hyaluronic Acid–Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic Cells
by: Laura Pandolfi, et al.
Published: (2019-09-01) -
Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment
by: Eleonora Vitali, et al.
Published: (2020-08-01) -
Preparation and study of two kinds of ophthalmic nano-preparations of everolimus
by: Zhan Tang, et al.
Published: (2019-01-01) -
The Role of Everolimus in Renal Cell Carcinoma
by: Malek Meskawi, et al.
Published: (2015-12-01)